TTF1 and gastric adenocarcinoma: This analysis revealed an expression of at least one enteric marker in 22.1% of 68 TTF-1 positive pulmonary adenocarcinomas while TTF-1 positivity was also seen in 66 colorectal, 9 pancreatic, and 8 gastric adenocarcinomas.